Shedding light on the EpCAM: An overview.


Journal

Journal of cellular physiology
ISSN: 1097-4652
Titre abrégé: J Cell Physiol
Pays: United States
ID NLM: 0050222

Informations de publication

Date de publication:
08 2019
Historique:
received: 01 10 2018
accepted: 30 11 2018
pubmed: 11 1 2019
medline: 21 5 2020
entrez: 11 1 2019
Statut: ppublish

Résumé

The epithelial cell adhesion molecule (EpCAM) is a Type I transmembrane superficial glycoprotein antigen that is expressed on the surface of basolateral membrane of multiple epithelial cells with some exceptions such as epidermal keratinocytes, hepatocytes, thymic cortical epithelial cells, squamous stratified epithelial cells, and myoepithelial cells that do not express the molecule. The molecule plays a pivotal role in the structural integrity, adhesion of the epithelial tissues and their interaction with the underlying layers. EpCAM prevents claudin-7 and claudin-1 molecules from degradation, thereby, decreasing the number of tight junctions and cellular interconnections, and promoting the cells toward carcinogenic transformation. Moreover, the mutations in the EpCAM gene lead to congenital tufting enteropathy, severe intestinal epithelium homeostasis disorders, and Lynch and Lynch syndrome. Overexpression of EpCAM on stem cells of some cancers and the presence of this molecule on circulating tumor cells (CTCs) makes it a promising candidate for cancer diagnosis as well as tracing and isolation of CTCs.

Identifiants

pubmed: 30628064
doi: 10.1002/jcp.28132
doi:

Substances chimiques

Biomarkers, Tumor 0
Epithelial Cell Adhesion Molecule 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

12569-12580

Informations de copyright

© 2019 Wiley Periodicals, Inc.

Auteurs

Seyed Muhammad Yahyazadeh Mashhadi (SM)

Department of Virology, Pasteur Institute of Iran, Tehran, Iran.
Antimicrobial Resistance Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Production Expert at Samandaroo 8 (Biotech Pharmaceutical) Co., Mashhad, Iran.

Monireh Kazemimanesh (M)

Department of Virology, Pasteur Institute of Iran, Tehran, Iran.

Arash Arashkia (A)

Department of Virology, Pasteur Institute of Iran, Tehran, Iran.

Kayhan Azadmanesh (K)

Department of Virology, Pasteur Institute of Iran, Tehran, Iran.

Zahra Meshkat (Z)

Antimicrobial Resistance Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.

Behrouz Golichenari (B)

Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran.

Amirhosein Sahebkar (A)

Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran.
Neurogenic inflammation Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH